Evidence map›Paper›PMID 21735094›Full record

ArticleMolecular and cellular biochemistry2011

A detailed thermodynamic profile of cyclopentyl and isopropyl derivatives binding to CK2 kinase.

Takayoshi Kinoshita, Yusuke Sekiguchi, Harumi Fukada, Tetsuko Nakaniwa, Toshiji Tada, Shinya Nakamura, Kazuo Kitaura, Hiroaki Ohno, Yamato Suzuki, Akira Hirasawa and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Copper Modulates the Catalytic Activity of Protein Kinase CK2.Frontiers in molecular biosciences · 2022
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Crystal structure of human CK2α at 1.06 Å resolution.Journal of synchrotron radiation · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Takayoshi KinoshitaGraduate School of Science, Osaka Prefecture University, 1-1 Gakuen-cho, Naka-ku, Sakai, Osaka 599-8531, Japan. kinotk@b.s.osakafu-u.ac.jp
Yusuke Sekiguchi
Harumi Fukada
Tetsuko Nakaniwa
Toshiji Tada
Shinya Nakamura
Kazuo Kitaura
Hiroaki Ohno
Yamato Suzuki
Akira Hirasawa
Isao Nakanishi
Gozoh Tsujimoto

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The detailed understanding of the molecular features of a ligand binding to a target protein, facilitates the successful design of potent and selective inhibitors. We present a case study of ATP-competitive kinase inhibitors that include a pyradine moiety. These compounds have similar chemical structure, except for distinct terminal hydrophobic cyclopentyl or isopropyl groups, and block kinase activity of casein kinase 2 subunit α (CK2α), which is a target for several diseases, such as cancer and glomerulonephritis. Although these compounds display similar inhibitory potency against CK2α, the crystal structures reveal that the cyclopentyl derivative gains more favorable interactions compared with the isopropyl derivative, because of the additional ethylene moiety. The structural observations and biological data are consistent with the thermodynamic profiles of these inhibitors in binding to CK2α, revealing that the enthalpic advantage of the cyclopentyl derivative is accompanied with a lower entropic loss. Computational analyses indicated that the relative enthalpic gain of the cyclopentyl derivative arises from an enhancement of a wide range of van der Waals interactions from the whole complex. Conversely, the relative entropy loss of the cyclopentyl derivative arises from a decrease in the molecular fluctuation and higher conformational restriction in the active site of CK2α. These structural insights, in combination with thermodynamic and computational observations, should be helpful in developing potent and selective CK2α inhibitors.

Indexed as

Adenosine TriphosphateBinding SitesCasein Kinase IIColorimetryCrystallography, X-RayCyclopentanesDrug DiscoveryEntropyHumansPentanesProtein BindingProtein Kinase InhibitorsAdenosine TriphosphateCasein Kinase IICyclopentanesisopentanePentanesProtein Kinase Inhibitors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.